[ET Net News Agency, 28 December 2023] LEPU BIO-B (02157) rose 9.2% to HK$3.93,
breaking above the 50-D SMA of HK$3.737.
It hits an intra-day high of HK$3.96, and an intra-day low of HK$3.55. The total shares
traded was 2.85 million, with a value of HK$10.94m. The active buy/sell ratio is 60:40,
with net buying turnover of HK$2.03m. BARCLAYS CAPITAL ASIA accounts for greatest net
responsive buying turnover of HK$525,254, with volume weighted average price of HK$3.838.
CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of
HK$603,624, with volume weighted average price of HK$3.849. The stock has risen a combined
11.6% over the past 2 consecutive trading days.
Basic Information
=================
--------------------------------
Nominal 3.930 % Chg +9.17%
High 3.960 Low 3.550
Shares Tr 2.85m Turnover 10.94m
10-D SMA 3.650 %H.V 59.400
20-D SMA 3.542 VWAP 3.841
50-D SMA 3.737 RSI14 59.772
--------------------------------
Status: Breaking above the 50-D SMA, active buy/sell ratio is 60:40, with net buying
turnover of HK$2.03m, rising a combined 11.6% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
LEPU BIO-B (02157) 3.93 +9.17
HUTCHMED (00013) 28.45 +4.40
GENSCRIPT BIO (01548) 20.00 +2.04
INNOVENT BIO (01801) 42.25 +4.19
EVEREST MED-B (01952) 21.00 +9.72
KEYMED BIO-B (02162) 48.45 +1.47
WUXI BIO (02269) 29.10 +5.82
BEIGENE (06160) 111.20 +2.30
ZAI LAB (09688) 20.80 +3.23
AKESO (09926) 45.40 +1.00
---------------------------------------------
(ed)